PIDTC: Hematopoietic Stem Cell Transplantation Using Carrier Donors for CD40L Deficiency Results in Excellent Outcomes
7 de sep. de 2022 ·
1m 54s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using...
mostra más
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh."
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
mostra menos
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
